We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+12.43%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$46.1B
AUM Growth
+$6.94B
(+18%)
Cap. Flow
+$2.24B
Cap. Flow
% of AUM
4.85%
Top 10 Holdings %
Top 10 Hldgs %
24.2%
Holding
995
New
107
Increased
596
Reduced
238
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$231M |
| 2 |
Amgen
AMGN
|
+$171M |
| 3 |
Johnson & Johnson
JNJ
|
+$158M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$153M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$209M |
| 2 |
Broadcom
AVGO
|
+$207M |
| 3 |
TJX Companies
TJX
|
+$195M |
| 4 |
Emerson Electric
EMR
|
+$193M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.07% |
| 2 | Healthcare | 17.55% |
| 3 | Financials | 10.75% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
IHS Holding
IHS
$2.77B
| $2.05M | ﹤0.01% |
444,883
| – | – |
|
777
CubeSmart
CUBE
$9.53B
| $1.99M | ﹤0.01% |
42,920
-4,245
| -9% | -$167K |
|
778
Blue Owl Capital
OBDC
$5.35B
| $1.97M | ﹤0.01% |
133,141
+36,006
| +37% | +$512K |
|
|
XRN
779
Chiron Real Estate Inc
XRN
$544M
| $1.94M | ﹤0.01% |
+34,979
| New | +$1.7M |
|
|
GTM
780
ZoomInfo Technologies
GTM
$861M
| $1.87M | ﹤0.01% |
100,875
-763,651
| -88% | -$12M |
|
781
Assurant
AIZ
$13.7B
| $1.85M | ﹤0.01% |
11,002
+5,997
| +120% | +$953K |
|
782
Varonis Systems
VRNS
$5.25B
| $1.83M | ﹤0.01% |
40,348
-875
| -2% | -$32.9K |
|
783
iShares MSCI Ireland ETF
EIRL
$74.9M
| $1.79M | ﹤0.01% |
29,205
-4,061
| -12% | -$226K |
|
784
GDS Holdings
GDS
$6.34B
| $1.76M | ﹤0.01% |
193,008
-10,400
| -5% | -$105K |
|
785
Fulcrum Therapeutics
FULC
$248M
| $1.73M | ﹤0.01% |
+256,888
| New | +$1.14M |
|
|
MASI
786
DELISTED
Masimo
MASI
| $1.68M | ﹤0.01% |
14,334
+6,862
| +92% | +$640K |
|
|
AKRO
787
DELISTED
Akero Therapeutics
AKRO
| $1.67M | ﹤0.01% |
+71,542
| New | +$1.41M |
|
788
Edgewise Therapeutics
EWTX
$4.39B
| $1.65M | ﹤0.01% |
+150,418
| New | +$1.06M |
|
789
EastGroup Properties
EGP
$11.5B
| $1.61M | ﹤0.01% |
8,754
-476
| -5% | -$81.3K |
|
790
Blackstone Secured Lending
BXSL
$5.41B
| $1.59M | ﹤0.01% |
57,497
+16,852
| +41% | +$465K |
|
791
Amcor
AMCR
$20.6B
| $1.58M | ﹤0.01% |
32,873
+6,759
| +26% | +$310K |
|
792
Westlake Corp
WLK
$9.46B
| $1.57M | ﹤0.01% |
11,223
+5,628
| +101% | +$714K |
|
793
Fox Class B
FOX
$20.7B
| $1.55M | ﹤0.01% |
56,137
+22,956
| +69% | +$645K |
|
794
GSK
GSK
$103B
| $1.55M | ﹤0.01% |
+41,852
| New | +$1.5M |
|
795
JD.com
JD
$40.8B
| $1.55M | ﹤0.01% |
53,544
+659
| +1% | +$17.9K |
|
796
GlobalFoundries
GFS
$29.4B
| $1.53M | ﹤0.01% |
26,004
+15,610
| +150% | +$865K |
|
|
LSXMK
797
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $1.52M | ﹤0.01% |
52,965
+26,702
| +102% | +$701K |
|
798
Liberty Global Class C
LBTYK
$3.27B
| $1.52M | ﹤0.01% |
81,473
+39,199
| +93% | +$679K |
|
799
Takeda Pharmaceutical
TAK
$55.1B
| $1.5M | ﹤0.01% |
+105,073
| New | +$1.49M |
|
800
Xenon Pharmaceuticals
XENE
$6.32B
| $1.48M | ﹤0.01% |
+32,036
| New | +$1.13M |
|
Similar funds
Aberdeen Group's Q4 2023 Portfolio in Review
As of Q4 2023, Aberdeen Group held 995 positions worth $46.1B, up 18% from $39.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Aberdeen Group deployed $2.24B of net new capital in Q4 2023, opening 107 new positions and adding to 596 existing holdings. Its largest new stake was Veralto: 984,184 shares worth $81M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Microsoft, an estimated $209M trimmed.
- Aberdeen Group's largest Q4 2023 buy was Veralto: 984,184 shares worth $81M.
- Aberdeen Group added most to NVIDIA in Q4 2023, an estimated $231M increase.
- Aberdeen Group's biggest Q4 2023 reduction was Microsoft, cutting an estimated $209M.
- Aberdeen Group fully exited VMware, Inc in Q4 2023, selling an estimated $61M.
- Aberdeen Group's ten largest holdings make up 24% of its $46.1B portfolio in Q4 2023.
- Aberdeen Group opened 107 new positions and closed 35 in Q4 2023.
- Aberdeen Group's portfolio value rose 18% quarter-over-quarter to $46.1B.
Based on Aberdeen Group's 13F filing for Q4 2023, filed 31 Jan 2024.